Thursday, June 14, 2018

GSK's two-drug HIV treatment meets main goal in late stage studies

  1. GSK's two-drug HIV treatment meets main goal in late stage studies  Reuters
  2. HIV treatment breakthrough boosts GSK  Financial Times
  3. ViiV Healthcare: GEMINI 1&2 Studies Meets Primary Endpoint - Quick Facts  NasdaqFull coverage
(CLICK HERE TO READ AND SEE MORE) 

0 comments:

Post a Comment

RSS FeedSUBSCRIBE TO RSS FEED!
FOLLOW US ON TWITTER!Follow us on Twitter!